Apyx Medical
APYX
63 hedge funds and large institutions have $123M invested in Apyx Medical in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 27 closing their positions.
593% more call options, than puts
Call options by funds: $1.98M | Put options by funds: $285K
4.17% more ownership
Funds ownership: 56.88% → 61.05% (+4.2%)
0% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 19
4% less capital invested
Capital invested by funds: $128M → $123M (-$4.69M)
11% less funds holding
Funds holding: 71 → 63 (-8)
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$5.46M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.52M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$3.06M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$1.75M |
| 5 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$1.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$7.42M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.31M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.15M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.12M |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$823K |
APYX Hedge Fund Activity: Q2 2022 in Review
63 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2022, worth a combined $123M — down 3.7% from $128M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of APYX and 20 opened new positions — a net loss of 7 holders — while 19 trimmed existing stakes and 19 added.
The largest buyer was Kent Lake Capital, adding an estimated $5.46M. The largest seller was BlackRock, cutting an estimated $7.42M.
- 63 institutional investors held Apyx Medical (APYX) as of Q2 2022, down from 71 in Q1 2022.
- Funds reported $123M of Apyx Medical stock for Q2 2022, down 3.7% quarter-over-quarter.
- 20 funds opened new Apyx Medical positions in Q2 2022 and 27 closed out, a net change of -7 holders.
- The largest Apyx Medical buyer in Q2 2022 was Kent Lake Capital, an estimated $5.46M added.
- The largest Apyx Medical seller in Q2 2022 was BlackRock, an estimated $7.42M sold.
Based on aggregated 13F filings for Q2 2022.